Free Daily Podcast Summary
Pharma and BioTech Daily: Daily Summaries Delivered
by Pharma and BioTech News
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai , a boutique AI & data studio.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 3 weeks ago5 min
Zealand Pharma & Generate Biomedicines' $1.2B AI Deal | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of exciting advancements and strategic shifts reshaping the landscape of drug development and patient care. A noteworthy collaboration between Zealand Pharma and Generate:Biomedicines is leading the charge, aiming to revolutionize treatment for obesity and metabolic diseases. This strategic partnership, valued at a potential $1.2 b...
- 3 weeks ago5 min
GSK Invests $800M in Biologics Facility | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some of the most compelling stories shaping the industry. Let's begin with GSK's bold move to expand its biologics capabilities. The company has announced an $800 million investment in a new biologics production facility and innovation hub in Pennsylvania. This state-of-the-art facility aims to address the increasing demand for biologic...
- 3 weeks ago4 min
Asahi Kasei's $920M AiCuris Buy Leads to FDA OK | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of compelling stories that highlight the dynamic nature of the industry, marked by strategic acquisitions, groundbreaking research, and significant regulatory milestones. Starting with Asahi Kasei's acquisition of Bayer spinout AiCuris for a substantial $920 million, this investment has culminated in the FDA approval of a novel her...
- 3 weeks ago4 min
GSK AI Partnership & Roche's FDA Win: $117M IPO Buzz | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of significant advancements and strategic shifts shaping the industry landscape. We begin with the integration of artificial intelligence into drug discovery. GSK's recent collaboration with Chai Discovery exemplifies the growing trend of using AI to transform research and development processes. By integrating AI into its drug ...
- 3 weeks ago4 min
Novartis' Rhapsido FDA Expansion Boosts Revenue Potential | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the most significant advancements and challenges shaping these dynamic sectors. In a notable regulatory update, the U.S. Food and Drug Administration has expanded the label for Novartis' Rhapsido to include symptomatic dermographism, based on compelling Phase 3 clinical trial data. Rhapsido, a small-molecule Bruton’s tyrosine kinase...
- 4 weeks ago4 min
Cerevance's Solengepras Hits Phase 3 Success for Parkinson's | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of impactful advancements and strategic shifts shaping the industry landscape. Cerevance has made headlines with its drug Solengepras achieving a major milestone in a Phase 3 trial for Parkinson's disease. The drug significantly reduced "off" time, those challenging periods when symptoms resurface as medication effects diminish...
- 4 weeks ago4 min
Shionogi Acquires Intrabio for $2B: Rare Disease Focus | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The pharmaceutical industry is no stranger to dynamic growth, as evidenced by Shionogi's recent acquisition of Intrabio for a staggering $2 billion. This move is more than just a financial transaction; it represents a strategic pivot towards addressing rare diseases. Through this acquisition, Shionogi gains access to Aqneursa, a drug approved for tackling two i...
- Oct 6, 20265 min
Bayer's $2.2B Ohio Site Boosts U.S. Pharma | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of groundbreaking advancements and strategic shifts that are defining the industry's path forward. Bayer has made headlines with its strategic $2.2 billion investment in a new Ohio manufacturing site. This move highlights the critical importance of strengthening domestic manufacturing capabilities, especially within the context...
Get Pharma and BioTech Daily summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
The Anthropic AI Daily Brief
Breaks down Anthropic's latest AI advancements and their real-world implications in clear, accessible language.
The AI Daily Brief: Artificial Intelligence News and Analysis
A daily analysis of artificial intelligence news, exploring its creative potential, industry impacts, and ethical challenges.
Global News Podcast
Global News Podcast AI
The AI in Business Podcast
Interviews with AI executives reveal practical applications and strategic insights for business leaders adopting AI.
Everyday AI Podcast – An AI and ChatGPT Podcast
Covers practical uses of AI tools like ChatGPT and Midjourney to help people work more efficiently and advance their careers.
The Best One Yet
A daily 20-minute podcast breaking down the three key business stories with sharp, accessible takes.
AI Daily: Claude News
Daily news on Claude AI, Anthropic updates, and advances in artificial intelligence, including models, research, and industry competition.
The Intelligence Shift
Industry leaders discuss how AI is transforming fields like sports, film, and healthcare with a Chief AI Officer.
AI Breakdown
Explores the latest advancements, ethical issues, and real-world impacts of artificial intelligence across industries.
The AI Podcast
Explores artificial intelligence advancements, trends, and ethics for enthusiasts and professionals.
Learn AI
Learn AI
Stock Movers
Short conversations analyzing today's biggest gainers and losers in global stock markets across major sectors.
About Pharma and BioTech Daily
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai , a boutique AI & data studio.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Pharma and BioTech Daily in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Pharma and BioTech Daily daily summary?
It's a free AI-powered email that summarizes new episodes of Pharma and BioTech Daily as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Pharma and BioTech Daily podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Pharma and BioTech Daily product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Pharma and BioTech News.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does Pharma and BioTech Daily release new episodes?
Pharma and BioTech Daily publishes daily. Our AI generates a summary within hours of each new episode.
What topics does Pharma and BioTech Daily cover?
Pharma and BioTech Daily covers topics including Science, News, Business, Investing, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Pharma and BioTech Daily summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.